Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The value of continuous glucose monitoring in the management of type 1 diabetes mellitus has not been determined. METHODS: In a multicenter clinical trial, we randomly assigned 322 adults and children who were already receiving intensive therapy for type 1 diabetes to a group with continuous glucose monitoring or to a control group performing home monitoring with a blood glucose meter. All the patients were stratified into three groups according to age and had a glycated hemoglobin level of 7.0 to 10.0%. The primary outcome was the change in the glycated hemoglobin level at 26 weeks. RESULTS: The changes in glycated hemoglobin levels in the two study groups varied markedly according to age group (P=0.003), with a significant difference among patients 25 years of age or older that favored the continuous-monitoring group (mean difference in change, -0.53%; 95% confidence interval [CI], -0.71 to -0.35; P<0.001). The between-group difference was not significant among those who were 15 to 24 years of age (mean difference, 0.08; 95% CI, -0.17 to 0.33; P=0.52) or among those who were 8 to 14 years of age (mean difference, -0.13; 95% CI, -0.38 to 0.11; P=0.29). Secondary glycated hemoglobin outcomes were better in the continuous-monitoring group than in the control group among the oldest and youngest patients but not among those who were 15 to 24 years of age. The use of continuous glucose monitoring averaged 6.0 or more days per week for 83% of patients 25 years of age or older, 30% of those 15 to 24 years of age, and 50% of those 8 to 14 years of age. The rate of severe hypoglycemia was low and did not differ between the two study groups; however, the trial was not powered to detect such a difference. CONCLUSIONS: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes. Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large trial of rt-CGM in people with type 1 diabetes showing significant reductions in HbA 1c in adults (159), improved glucose control was not seen in children (ages 8 to 14 years) or adolescents and young adults (ages 15 to 24 years).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Most randomized controlled trials (RCTs) in adults with type 1 diabetes show that rt-CGM leads to lower HbA 1c (156-159) and reduced time in the hypoglycemic range (160,161).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Integration of continuous glucose monitoring (CGM) into the treatment plan soon after diagnosis improves glycemic outcomes, decreases hypoglycemic events, and improves quality of life for individuals with type 1 diabetes (18-23).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [22]
In the citing paper
“Tamborlane and colleagues91 reported that a real-time continuous glucose monitoring system decreased the amount of time spent in hypoglycaemia (<4 mmol/L [70 mg/dL]) and lowered HbA1C when used by patients an average of 6 days a week.”
From Type 1 diabetes (2014) · cites this paper as [91]
In the citing paper
“In this study, the degree of HbA1C reduction directly correlated with higher HbA1C concentrations before beginning continuous glucose monitoring.”
From Type 1 diabetes (2014) · cites this paper as [91]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Self-citationStandards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Self-citationEpidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Research works printed but not linked: 1
- Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley, 1987.
Cited by
Items 601–700 of 1,001
Type 1 diabetes: where are we in 2017?
Copenhaver, M. M., & Hoffman, R. P. (2017) · Translational Pediatrics · doi:10.21037/tp.2017.09.09 · Cited by 34
Bianchi, C., Aragona, M., Rodia, C., Baronti, W., Gennaro, G., Bertolotto, A., & Prato, S. D. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.10.012 · Cited by 31
Sampled-data Observer-based Glucose Control for the Artificial Pancreas
Borri, A., Palumbo, P. J., Manes, C., Panunzi, S., & Gaetano, A. D. (2017) · Acta Polytechnica Hungarica · doi:10.12700/aph.14.1.2017.1.6 · Cited by 30
A New Horizon for Glucose Monitoring
Dovč, K., Bratina, N., & Battelino, T. (2015) · Hormone Research in Paediatrics · doi:10.1159/000368924 · Cited by 30
Continuous Glucose Monitor Shows Potential for Early Hypoglycemia Detection in Hospitalized Patients
Ryan, M. T., Savarese, V. W., Hipszer, B. R., Dizdarevic, I., Joseph, M., Shively, N. R., & Joseph, J. I. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0071 · Cited by 27
Fonda, S. J., Salkind, S. J., Walker, M. S., Chellappa, M., Ehrhardt, N. M., & Vigersky, R. A. (2012) · Diabetes Care · doi:10.2337/dc12-1225 · Cited by 28
Technology use in transition-age patients with type 1 diabetes: reality and promises
Los, E., Ulrich, J., & Guttmann-Bauman, I. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816632543 · Cited by 28
Update on Clinical Utility of Continuous Glucose Monitoring in Type 1 Diabetes
Haviland, N., Walsh, J. S. A., Roberts, R., & Bailey, T. S. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0808-5 · Cited by 29
Vergnes, J., Arrivé, É., Gourdy, P., Hanaire, H. P., Rigalleau, V., Gin, H., Sédarat, C., Dorignac, G., Bou, C., Sixou, M., et al. (2009) · Trials · doi:10.1186/1745-6215-10-65 · Cited by 27
FDA Approval of Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing
Shapiro, A. R. (2017) · JAMA · doi:10.1001/jama.2017.12075 · Cited by 26
Optimizing Recruitment of Black Adolescents into Behavioral Research: A Multi-Center Study
Ellis, D. A., Rhind, J., Carcone, A. I., Evans, M. A., Weissberg-Benchell, J. A., Buggs‐Saxton, C., Boucher‐Berry, C., Miller, J. L., Wazeer, M. A., Drossos, T., et al. (2021) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsab008 · Cited by 27
Tanenbaum, M. L., Messer, L. H., Wu, C., Basina, M., Buckingham, B. A., Hessler, D., Mulvaney, S. A., Maahs, D. M., & Hood, K. K. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109048 · Cited by 29
Murata, T., Hosoda, K., Nishimura, K., Miyamoto, Y., Sakane, N., Satoh‐Asahara, N., Toyoda, M., Hirota, Y., Matsuhisa, M., Kuroda, A., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110147 · Cited by 36
Branco, R. G., Chavan, A., & Tasker, R. C. (2009) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181c59144 · Cited by 28
Jenkins, A. J., Krishnamurthy, B., Best, J. D., Cameron, F. J., Colman, P. G., Hamblin, P. S., O’Connell, M. A., Rodda, C. P., Teede, H. J., & O'Neal, D. N. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0139 · Cited by 26
Rigla, M. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500109 · Cited by 27
Benefits of Short-Term Professional Continuous Glucose Monitoring in Clinical Practice
Leinung, M., Nardacci, E., Patel, N., Bettadahalli, S., Paika, K., & Thompson, S. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0027 · Cited by 26
Conget, I., Battelino, T., Giménez, M., Gough, H., Castañeda, J., & Bolinder, J. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0107 · Cited by 26
Interstitium: The next diagnostic and therapeutic platform in critical illness
Venkatesh, B., Morgan, T. J., & Cohen, J. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f24406 · Cited by 28
Pepper, G. M., Steinsapir, J., & Reynolds, K. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0030 · Cited by 26
The rise of technology in diabetes care. Not all that is new is necessarily better
Acerini, C. L. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12366 · Cited by 28
Rasbach, L. E., Volkening, L. K., Markowitz, J. T., Butler, D. A., Katz, M. L., & Laffel, L. M. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0366 · Cited by 30
Ellis, D. A., Carcone, A. I., Ondersma, S. J., Naar‐King, S., Dekelbab, B. H., & Moltz, K. C. (2017) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2016.0182 · Cited by 27
Brinkman, A. K. (2017) · Nursing Clinics of North America · doi:10.1016/j.cnur.2017.07.001 · Cited by 42
Technology and the issue of cost/benefit in diabetes
Giannini, C., Mohn, A., & Chiarelli, F. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.986 · Cited by 29
Continuous Glucose Monitoring — Coming of Age
Wolpert, H. A. (2010) · New England Journal of Medicine · doi:10.1056/nejme1006098 · Cited by 26
Glocker, V., Bachmann, S., Hess, M., Szinnai, G., & Burckhardt, M.-A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.958671 · Cited by 25
Yauch, L. M., Velazquez, E. P., Piloya, T., Mungai, L., Omar, A. A., & Moran, A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.135 · Cited by 28
Meyhöfer, S., Wilms, B., Ihling, F., Windjäger, A., Kalscheuer, H., Augustinov, A., Herrmann, V., Lehnert, H., & Schmid, S. M. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13914 · Cited by 25
An Overview of Continuous Glucose Monitoring Systems
Cox, M. A. (2009) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2009.06.002 · Cited by 25
Cohen, O., Körner, A., Chlup, R., Zoupas, C., Константинович, Р. А., Wudi, K., Bartášková, D., Pappas, A., Niederland, T., Taybani, Z. J., et al. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300429 · Cited by 26
Vettoretti, M., Facchinetti, A., Favero, S. D., Sparacino, G., & Cobelli, C. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2015.2426217 · Cited by 28
Dril, E. V., & Schumacher, C. (2019) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1088 · Cited by 31
Glucose fluctuations promote vascular BK channels dysfunction via PKCα/NF-κB/MuRF1 signaling
Zhang, Z., Qian, L., Wang, N., Miao, L.-F., Ma, X., Dang, S., Wu, Y., Liu, X., Li, X., Chai, Q., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.05.021 · Cited by 28
Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment.
(2018) · Europe PMC (PubMed Central) · Cited by 64
A Quantitative Look Inside the Body: Minimally Invasive Infrared Analysis in Vivo
Vrančić, C., Kröger‐Lui, N., Gretz, N., Neudecker, S., Pucci, A., & Petrich, W. H. (2014) · Analytical Chemistry · doi:10.1021/ac5028808 · Cited by 26
Kalyani, R. R., Allende-Vigo, M. Z., Antinori-Lent, K. J., Close, K. L., Das, S. R., Deroze, P., Edelman, S. V., El Sayed, N. A., Kerr, D., Neumiller, J. J., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad745 · Cited by 25
Torre, E. L. M., García, T. T., Millán, C. O., Pérez, J. A. F., Mayor, R. G., & Fernández, M. L. L. (2012) · Avances en Diabetología · doi:10.1016/j.avdiab.2012.01.002 · Cited by 30
Escaping the Hemoglobin A1c-Centric World in Evaluating Diabetes Mellitus Interventions
Vigersky, R. A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815576363 · Cited by 26
Deep transfer learning: a novel glucose prediction framework for new subjects with type 2 diabetes
Yu, X., Yang, T., Lu, J., Shen, Y., Lu, W., Zhu, W., Bao, Y., Li, H., & Zhou, J. (2021) · Complex & Intelligent Systems · doi:10.1007/s40747-021-00360-7 · Cited by 31
Segev, N., Hornung, L., Tellez, S. E., Courter, J. D., Lawson, S. A., Nathan, J., Abu-El-Haija, M., & Elder, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091893 · Cited by 19
Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset
Edqvist, J., Rawshani, A., Rawshani, A., Adiels, M., Franzén, S., Bjorck, L. M., Svensson, J., Lind, M., Sattar, N. A., & Rosengren, A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002187 · Cited by 25
Kruger, D. F., & Anderson, J. E. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0193 · Cited by 30
The Role of Reimbursement in the Adoption of Continuous Glucose Monitors
Bartelme, A., & Bridger, P. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300449 · Cited by 24
A Just-in-Time Learning Based Monitoring and Classification Method for Hyper/Hypocalcemia Diagnosis
Peng, X., Tang, Y. S., He, W., Du, W., & Qian, F. (2017) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2017.2655522 · Cited by 24
Ellis, D. A., Carcone, A. I., Naar‐King, S., Rajkumar, D., Palmisano, G., & Moltz, K. C. (2017) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsx144 · Cited by 25
Tissue Response to Subcutaneous Infusion Catheter
Zhang, E., & Cao, Z. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819837972 · Cited by 24
Diabetes technology and treatments in the paediatric age group
Shalitin, S., & Chase, H. P. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02582.x · Cited by 30
Siddiqui, N. A., Billa, N., Roberts, C. J., & Osei, Y. A. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8040030 · Cited by 25
Immune Intervention in Type I Diabetes Mellitus
Ludvigsson, J. (2013) · InTech eBooks · doi:10.5772/52801 · Cited by 24
Practical Considerations in the Use of Real-Time Continuous Glucose Monitoring Alerts
Mastrototaro, J. J., Welsh, J. B., & Lee, S. D. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400329 · Cited by 26
Kim, S. K., Kim, H. J., Kim, T., Hur, K. Y., Kim, S. W., Lee, M.-K., Min, Y.-K., Kim, K.-W., Chung, J. H., & Kim, J. H. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.6.449 · Cited by 23
Youth Involvement in the Decision to Start CGM Predicts Subsequent CGM Use
Miller, V. A., Xiao, R., Slick, N., Feudtner, C., & Willi, S. M. (2020) · Diabetes Care · doi:10.2337/dc20-0348 · Cited by 23
Continuous Glucose Monitoring in Older Adults: What We Know and What We Have Yet to Learn
Price, C. E., Callahan, K. E., Aloi, J., & Usoh, C. O. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241234651 · Cited by 25
Perioperative use and accuracy of continuous glucose monitoring: A systematic review
Carlier, L., de Ponthaud, C., Jacqueminet, S., Phan, F., Gaujoux, S., & Amouyal, C. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16583 · Cited by 30
Progress of artificial pancreas devices towards clinical use: the first outpatient studies
Russell, S. J. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000142 · Cited by 28
Pettus, J., & Edelman, S. V. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816639069 · Cited by 23
Chinese clinical guidelines for continuous glucose monitoring (2018 edition)
Bao, Y., Chen, L., Chen, L., Dou, J., Gao, Z., Gao, L., Guo, L., Guo, X., Ji, L., Ji, Q., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3152 · Cited by 24
“In type 2 diabetes, studies have also suggested that both retrospective and real‐time CGM are powerful device to change patients' lifestyle and to improve their glycemic variability.74 Women with diabetes during pregnancy and gestational diabetes may also benefit from CGM.”
BackgroundInfluentialThe closed‐loop artificial pancreas in 2020
Fabris, C., & Kovatchev, B. P. (2020) · Artificial Organs · doi:10.1111/aor.13704 · Cited by 24
From wearables to THINKables: artificial intelligence-enabled sensors for health monitoring
Mirmomeni, M., Fazio, T., von Cavallar, S., & Harrer, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819246-7.00012-7 · Cited by 30
Scalzo, P. (2021) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721721995478 · Cited by 22
Accuracy of CGM Systems During Continuous and Interval Exercise in Adults with Type 1 Diabetes
Prato, G. D., Pasquini, S., Rinaldi, E., Lucianer, T., Donà, S., Santi, L., Negri, C., Bonora, E., Moghetti, P., & Trombetta, M. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211023522 · Cited by 26
Measurement delay associated with the Guardian® RT continuous glucose monitoring system
Wei, C., Lunn, D. J., Acerini, C. L., Allen, J. M., Larsen, A. M., Wilinska, M. E., Dunger, D. B., & Hovorka, R. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02887.x · Cited by 23
Olinder, A. L., Nyhlin, K. T., & Smide, B. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00688.x · Cited by 28
Mezquita‐Raya, P., Reyes‐García, R., Moreno, Ó., Muñoz‐Torres, M., Merino-Torres, J. F., Martínez, J. J. G., Jódar-Gimeno, E., Escalada, J., Gargallo-Fernández, M., Soto-González, A., et al. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.04.005 · Cited by 29
Jump Neural Network for Real-Time Prediction of Glucose Concentration
Zecchin, C., Facchinetti, A., Sparacino, G., & Cobelli, C. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2239-0_15 · Cited by 25
Reed, J., Dong, T., Eaton, E., Friswold, J., Porges, J., Al‐Kindi, S. G., Rajagopalan, S., & Neeland, I. J. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15608 · Cited by 22
Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes
Friedman, J. G., Coyne, K., Aleppo, G., & Szmuilowicz, E. D. (2023) · Endocrine Connections · doi:10.1530/ec-23-0085 · Cited by 22
Expanding the horizon of continuous glucose monitoring into the future of pediatric medicine
Morales-Dopico, L., & MacLeish, S. A. (2024) · Pediatric Research · doi:10.1038/s41390-024-03573-x · Cited by 25
Kim, J. H. (2020) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040038.019 · Cited by 22
The Evolution of Diabetes Technology – Options Toward Personalized Care
Zahid, M., Dowlatshahi, S., Kansara, A., & Sadhu, A. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.04.007 · Cited by 24
Use of Continuous Glucose Monitoring System in the Management of Severe Hypoglycemia
Ryan, E. A., & Germsheid, J. C. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0042 · Cited by 22
Radermecker, R. P., Remy, A. S., Scheen, A. J., Bringer, J., & Renard, É. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.08.001 · Cited by 22
Sherr, J. L., Tamborlane, W. V., Xing, D., Tsalikian, E., Mauras, N., Buckingham, B. A., White, N. H., Arbeláez, A. M., Beck, R. W., Kollman, C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2190 · Cited by 23
de Bock, M. I., Cooper, M. N., Retterath, A. J., Nicholas, J. A., Ly, T. T., Jones, T. W., & Davis, E. A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633484 · Cited by 23
Chaugule, S., & Graham, C. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1360312 · Cited by 24
Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes
Chan, C. L. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0905-0 · Cited by 22
Ridder, F. D., den Brinker, M., & Block, C. E. M. D. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819865399 · Cited by 23
György, J., Gaál, Z., Gerő, L., Hídvégi, T., Kempler, P., Winkler, G., & Wittmann, I. (2017) · Diabetologia Hungarica · doi:10.24121/dh.2017.1 · Cited by 39
Banting Memorial Lecture 2014 Technology and diabetes care: appropriate and personalized
Pickup, J. C. (2014) · Diabetic Medicine · doi:10.1111/dme.12613 · Cited by 22
Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems
Tauschmann, M., & Hovorka, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.910192 · Cited by 24
Grunberger, G., Bailey, T. S., Camacho, P. M., EINHORN, D. F., Garber, A. J., Handelsman, Y., Harrell, R. M., Lando, H. M., Law, B., Leffert, J. D., et al. (2015) · Endocrine Practice · doi:10.4158/ep15653.cs · Cited by 22
the Italian Study Group on Diffusion of CSII in Italy, Bonfanti, R., Lepore, G., Bozzetto, L., Corsi, A., Blasi, V. D., Girelli, A., Grassi, G., Iafusco, D., Rabbone, I., et al. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0810-4 · Cited by 23
Diabetes technology and the human factor
Liberman, A., Buckingham, B. A., & Phillip, M. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02583.x · Cited by 24
Micheletto, F., Man, C. D., Kolterman, O., Chiquette, E., Herrmann, K., Schirra, J. R. J., Kovatchev, B. P., & Cobelli, C. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0054 · Cited by 23
Lawson, M. L., Bradley, B., McAssey, K., Clarson, C. L., Kirsch, S. E., Mahmud, F. H., Curtis, J. R., Richardson, C., Courtney, J. M., Cooper, T., et al. (2014) · BMC Pediatrics · doi:10.1186/1471-2431-14-183 · Cited by 21
Sato, J., Kanazawa, A., Ikeda, F., Shigihara, N., Kawaguchi, M., Komiya, K., Uchida, T., Ogihara, T., Mita, T., Shimizu, T., et al. (2016) · Journal of International Medical Research · doi:10.1177/0300060515600190 · Cited by 22
Who Should Be Considered for Islet Transplantation Alone?
Othonos, N., & Choudhary, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0847-6 · Cited by 24
McGill, D. E., Volkening, L. K., Butler, D. A., Harrington, K. R., Katz, M. L., & Laffel, L. M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0037 · Cited by 22
Moreno-Fernández, J., Pazos-Couselo, M., González‐Rodríguez, M., Rozas, P., Delgado‐Rodríguez, M., Aguirre, M., & López, J. M. G. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.04.003 · Cited by 28
In Vitro Sugar Interference Testing With Amperometric Glucose Oxidase Sensors
Boehm, R. D., Donovan, J. W., Sheth, D., Durfor, A., Roberts, J. R., & Isayeva, I. S. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818791538 · Cited by 23
Hug, S. A., Riond, B., & Schwarzwald, C. C. (2013) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12072 · Cited by 23
Role of continuous glucose monitoring in diabetes management
Moser, E. G., Crew, L. B., & Garg, S. K. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)62002-9 · Cited by 22
Can Diabetes Be Cured? Potential Biological and Mechanical Approaches
Saudek, C. D. (2009) · JAMA · doi:10.1001/jama.2009.508 · Cited by 26
Pfützner, A., Jensch, H., Cardinal, C., Srikanthamoorthy, G., Riehn, E., & Thomé, N. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221095573 · Cited by 20
Tumminia, A., Sciacca, L., Frittitta, L., Squatrito, S., Vigneri, R., Le Moli, R., & Tomaselli, L. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s69482 · Cited by 20
Forlenza, G. P., Pyle, L. L., Maahs, D. M., & Dunn, T. C. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12474 · Cited by 22
Rose, L., Klausmann, G., & Seibold, A. (2021) · Diabetes Therapy · doi:10.1007/s13300-020-00978-9 · Cited by 18
Time in Range as a Research Outcome Measure
Timmons, J. G., Boyle, J. G., & Petrie, J. R. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0097 · Cited by 23
Cichosz, S. L., Olesen, S. S., & Jensen, M. H. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241286907 · Cited by 27
Metadata
- Authors
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Affiliations
- Yale University (US)
- Corresponding author
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-02
- Volume
- 359
- Issue
- 14
- Pages
- 1464-1476
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1531505795
- Semantic Scholar
- b1462f3524589cf66909ea165b57d41352a0293b
- Cited by
- 1,559
- References
- 30
- Citations by year
- 2026: 29 · 2025: 60 · 2024: 64 · 2023: 54 · 2022: 61 · 2021: 103 · 2020: 104 · 2019: 90 · 2018: 109 · 2017: 101 · 2016: 95 · 2015: 85 · 2014: 79 · 2013: 86 · 2012: 104
- FWCI
- 79.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, intensive insulin therapy, HbA1c, glycemic control, age differences, children and adolescents, severe hypoglycemia
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Insulin Infusion Systems, Male, Blood Glucose Self-Monitoring, Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.